Table 3 PCI procedural data and incidence of PMI in the BUDO and BUDAO groups.
Variables | BUDO group (n = 165) | BUDAO group (n = 165) | P value |
---|---|---|---|
Pre-dilation | |||
PRDB MD (mm) | 2.57 ± 0.32 | 2.53 ± 0.36 | 0.214 |
PRDB length (mm) | 13.93 ± 2.82 | 14.27 ± 3.11 | 0.293 |
PRDB PRMP (atm) | 13.32 ± 2.69 | 13.80 ± 3.19 | 0.143 |
Pre-diated number | 3.00 ± 1.05 | 2.85 ± 0.81 | 0.145 |
Pre-diated TT (s) | 9.98 ± 3.60 | 9.62 ± 2.82 | 0.317 |
Stent implantation | |||
Stent number | 1.59 ± 0.72 | 1.48 ± 0.64 | 0.148 |
Stent AD (mm) | 3.07 ± 0.47 | 3.02 ± 0.42 | 0.256 |
Stent TL (mm) | 40.81 ± 21.49 | 38.38 ± 18.79 | 0.276 |
Stent DMP (atm) | 10.13 ± 1.99 | 9.98 ± 1.67 | 0.474 |
Stent DTT (s) | 6.36 ± 2.94 | 6.42 ± 2.29 | 0.835 |
Post-dilation | |||
PODB MD (mm) | 3.25 ± 0.49 | 3.16 ± 0.48 | 0.110 |
PODB length (mm) | 12.12 ± 2.22 | 12.19 ± 2.26 | 0.769 |
PODB POMP (atm) | 18.80 ± 2.43 | 18.56 ± 2.53 | 0.376 |
Post-dilated number | 3.64 ± 1.05 | 3.45 ± 1.20 | 0.121 |
Post-dilated TT (s) | 12.27 ± 3.46 | 11.78 ± 3.31 | 0.190 |
During PCI | |||
IVUS use (%) | 24 (14.55%) | 20 (12.12%) | 0.627 |
IABP use (%) | 2 (1.21%) | 0 (0.00%) | 0.498 |
No/slow blood flow (%) | 2 (1.21%) | 4 (2.42%) | 0.685 |
Verapamil use (%) | 1 (0.61%) | 4 (2.42%) | 0.371 |
Tirofiban use (%) | 1 (0.61%) | 0 (0.00%) | 1.000 |
Operation time (min) | 40.52 ± 24.72 | 43.22 ± 23.76 | 0.312 |
After PCI | |||
PMI (%) | 115 (69.70%) | 102 (61.82%) | 0.164 |
MPMI (%) | 81 (49.09%) | 70 (42.42%) | 0.269 |